This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Qian MX , Odwyer PJ , Gallo JM
High-Performance Liquid-Chromatographic Method for the Determination of Ag-331, a Novel Anticancer Agent, in Human Serum and Urine Using Solid-Phase Extraction and Photodiode- Array Detection
Journal of Chromatography B-Biomedical Applications. 1995 Apr 21;666(2) :307-314
AbstractA reversed-phase isocratic high-performance liquid chromatographic method has been developed for the determination of AG-331, a novel thymidylate synthase inhibitor, in human serum and urine. The method involves a solid-phase extraction from C-18 cartridges without addition of an internal standard. The methanol eluent is evaporated under nitrogen at 40 degrees C, and reconstituted in mobile phase, acetonitrile-water (35:65, v/v) containing 25 mM ammonium phosphate. Separation of AG-331 was obtained on a C-18 column at a flow-rate of 1 ml/min. Chromatographic signals were monitored by a photodiode- array detector at a primary wavelength of 457 nm with a bandwidth of 4.8 nm. Standard curves are linear in the range of 22-2175 ng/ml in plasma and 44-2175 ng/ml in urine, respectively. The extraction recovery ranged from 92.9-102.4%. Intra-day coefficient of variation was less than 9.5%, and inter-day coefficient of variation was less than 14.3% for an AG-331 concentration of 44 ng/ml. This method has been used to characterize the pharmacokinetics of AG-331 in cancer patients as part of ongoing Phase I trials.
NotesTimes Cited: 1 Article QW512 J CHROMATOGR B-BIO MED APPL